M
Michela Salvatici
Researcher at European Institute of Oncology
Publications - 39
Citations - 2101
Michela Salvatici is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Cardiotoxicity & Ejection fraction. The author has an hindex of 18, co-authored 38 publications receiving 1768 citations.
Papers
More filters
Journal ArticleDOI
Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation
Daniela Cardinale,Alessandro Colombo,Rosalba Torrisi,Maria T. Sandri,Maurizio Civelli,Michela Salvatici,Giuseppina Lamantia,Nicola Colombo,Sarah Cortinovis,Maria A. Dessanai,Franco Nolè,Fabrizio Veglia,Carlo M. Cipolla +12 more
TL;DR: TNI+ identifies trastuzumab-treated patients who are at risk for cardiotoxicity and are unlikely to recover from cardiac dysfunction despite HF therapy.
Journal ArticleDOI
N-Terminal Pro-B-Type Natriuretic Peptide after High-Dose Chemotherapy: A Marker Predictive of Cardiac Dysfunction?
Maria T. Sandri,Michela Salvatici,Daniela Cardinale,Laura Zorzino,Rita Passerini,Paola Lentati,Maria Elena Leon,Maurizio Civelli,Giovanni Martinelli,Carlo M. Cipolla +9 more
TL;DR: Persistently increased NT-proBNP early after administration of HDC is strongly associated with development of cardiac dysfunction, and has important implications for identifying patients at risk of developing chemotherapy-induced cardiotoxicity.
Journal ArticleDOI
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
Franco Nolè,Elisabetta Munzone,Laura Zorzino,Ida Minchella,Michela Salvatici,Edoardo Botteri,M. Medici,Elena Verri,Laura Adamoli,Nicole Rotmensz,A. Goldhirsch,M. T. Sandri +11 more
TL;DR: CTCs basal value is a predictive indicator of prognosis and changes in CTC levels during therapy may indicate a clinical response, which might substitute other measurement parameters for response evaluation.
Journal ArticleDOI
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
Daniela Cardinale,Fabio Ciceri,Roberto Latini,Maria Grazia Franzosi,Maria Teresa Sandri,Maurizio Civelli,GianFranco Cucchi,Elisabetta Menatti,Maurizio Mangiavacchi,Raffaele Cavina,Enrico Barbieri,Stefania Gori,Alessandro Colombo,Giuseppe Curigliano,Michela Salvatici,Antonio Rizzo,Francesco Ghisoni,Alessandra Bianchi,Cristina Falci,Michele Aquilina,Andrea Rocca,Anna Monopoli,Carlo Milandri,Giuseppe Rossetti,Marco Bregni,Marco Sicuro,Alessandra Malossi,Daniele Nassiacos,Claudio Verusio,Monica Giordano,Lidia Staszewsky,Simona Barlera,Enrico Nicolis,Michela Magnoli,Serge Masson,Carlo M. Cipolla,C.M. Cipolla,D. Cardinale,F. Ciceri,R. Latini,M.T. Sandri,Aldo P. Maggioni,R. Labianca,M. Tettamanti,Michele Senni,A. Finzi,F. Grosso,Tarcisio Vago,M. Civelli,Silvana Gramenzi,S. Masson,G. Balconi,Roberto Bernasconi,M. Salvatici,E. Nicolis,S. Barlera,M. Magnoli,M.G. Buratti,M.L. Ojeda Fernandez,MariaGrazia Franzosi,L. Staszewsky,A. Vasamì,A. Malossi,M. Sicuro,B. Thiebat,C. Barè,A. Corzani,F. Coccolo,S. Colecchia,C. Pellegrini,M. Bregni,L. Appio,I. Caico,G. Rossetti,O. Mesenzani,Carlo Campana,M. Giordano,M. Gilardoni,G. Scognamiglio,G. Corrado,D. Battagin,F. De Rosa,C. Carpino,S. Palazzo,A. Monopoli,C. Milandri,P.G. Giannessi,G. Zipoli,F. Ghisoni,A. Rizzo,P. Pastori,S. Callegari,C. Sesenna,A. Colombo,Giuseppe Curigliano,C. Fodor,M. Mangiavacchi,R. Cavina,D. Guiducci,R. Mazza,Fabio Turazza,P. Vallerio,L. Marbello,E. Sala,G. Fragasso,S. Trinca,M. Aquilina,A. Rocca,A. Farolfi,D. Andreis,S. Gori,E. Barbieri,L. Lanzoni,F. Marchetti,C. Falci,A. Bianchi,E. Mioranza,A. Banzato,Federica Re,N. Gaibazzi,M. Gullo,M.C. Turina,Elena Gervasi,F. Giaroli,D. Nassiacos,C. Verusio,B. Barco,A. Bertolini,G. Cucchi,E. Menatti,Gianfranco Sinagra,Aneta Aleksova,A. Guglielmi,G. Pinotti,R. Gueli,C. Mongiardi,I. Vallini +136 more
TL;DR: Low cumulative doses of anthracyclines in adult patients with low cardiovascular risk can raise troponins, without differences between the two strategies of giving enalapril.
Journal ArticleDOI
Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples
Maria T. Sandri,Paola Lentati,Elvira Benini,Patrizia Dell'Orto,Laura Zorzino,Francesca Carozzi,Patrick Maisonneuve,Rita Passerini,Michela Salvatici,Chiara Casadio,Sara Boveri,Mario Sideri +11 more
TL;DR: This study shows that the HC2 assay and the AMPLICOR HPV test give comparable results, with both being suitable for routine use, and the differences noted in some cases may suggest a different optimal clinical use.